studies was to examine in detail the haemo-
1. Administration of adrenwrticotropic hormone (ACTH) to sheep produced increases in mean arterial pressure within 24 h associated with an increase in cardiac output and cardiac rate. Both cardiac output and blood pressure remained elevated over the 5 days of ACTH treatment.
2. Administration of ACTH during Badrenoreceptor blockade resulted in an increase in blood pressure without changes in cardiac output at 24 h.
3. Administration of a combined steroid infusion over 5 days produced increases in cardiac output identical with the effects of ACTH but with a substantially smaller effect on blood pressure.
4. These data suggest that the observed changes in cardiac output produced by ACTH treatment may be associated with high blood concentrations of adrenocortical steroids rather than being necessary for the development of the hypertension. dynamic changes which are associated with the development of ACTH-induced hypertension in sheep. Three separate studies were carried out. The protocols for each of the three studies were similar and included a pretreatment period of 3 days, a 5 day ACTH-or steroid-infusion period and a post-treatment period of 3 days. In the 8-adrenoreceptor-blockade experiments, acebutolol (May and Baker Pty. Ltd) was infused intra--venously at 10 or 20 mg day-' kg-' for 3-5 days before ACTH treatment and for remainder of the experiment. Adequacy of /3-receptor blockade was assessed by heart rate response to isoprenaline injection at five different doses. ACTH (Synacthen, CIBA-GEIGY) was injected intramuscularly, 2 i.u. day-' kg-I for 5 days. The combined steroid infusion consisted of cortisol (5 mg/h); corticosterone (0.5 mg/h); 1 1-deoxycortisol (1 mg/h); deoxycorticosterone (25 ,ug/h); aldosterone (3 pg/h). This infusion produced blood concentrations of these steroids similar to those found after ACTH treatment .
Blood pressure, cardiac rate and cardiac output were measured daily between 10.00 and 12.00 hours. Water and food intake, urine output and plasma and urine "A+] and [K+] were also measured daily. Cardiac output was measured by thermodilution either with a pulmonary arterial or with an aortic thermistor. For each determination 10 ml of isotonic sodium chloride solution at O°C was injected into the right atrium. A total of six thermodilution curves was obtained over a period of 10 min for each cardiac output determination. Stroke volume and total peripheral resistance were calculated. Results were expressed as mean ? SEM and analysed by using ANOVA or Student's t-test.
Results

Study 1: haemodynamic effects of ACTH (n = 15)
The mean changes in mean arterial pressure, cardiac output, cardiac rate, stroke volume and total peripheral resistance are shown in Fig. 1 .
Increases in blood pressure were seen within 24 h and were associated with an increase in cardiac output from 4.6 f 0.1 to 5.5 k 0.2 litres/min, which was due entirely to an increase in cardiac rate. After 5 days cardiac output had increased to The dose of acebutolol used (10 or 20 mg/day-' kg-') over a 3-5 day period had no effect on basal blood pressure or cardiac output but resulted in a 20-fold reduction in the heart rate response to injections of isoprenaline. Administration of ACTH during acebutolol infusion produced increases in mean arterial pressure identical with those seen with ACTH alone in the same sheep. The increase in blood pressure over the first 24 h of ACTH treatment (64.5 f 2 to 77 f 3 mmHg) occurred without change in cardiac output in acebutolol-treated sheep (4.6 f 0.15 litres/min control, 4.7 f 0.15 litres/min on day 1 ACTH). However, cardiac output did not remain at these control values and had risen to 5.5 k 0.3 litredmin on day 5 of ACTH administration. Changes in heart rate and stroke volume were similar to those obtained with ACTH alone. Total peripheral resistance was significantly higher on both days 1 and 5 of ACTH treatment during 8-adrenoreceptor blockade when compared with ACTH alone. Metabolic effects of ACTH in animals receiving acebutolol were similar to those seen with ACTH alone.
Study 3: effect of combined steroid infusion (n = 6) The combined steroid infusion reproduced all the metabolic features of ACTH treatment but had substantially less effect on blood pressure. After 5 days mean arterial pressure had risen from 66 f 2 to 75 f 1 mmHg (A = +9 mmHg) compared with an increase of from 68 rf: 1 to 88 f 4 mmHg (A = +20 mmHg) after ACTH treatment. Despite these substantial differences in blood pressure response, changes in cardiac output were identical in the two groups. With combined steroid infusion cardiac output rose from 4 6 f 0.2 to 5.6 f 0.4 litres/min on day 5, a value similar to that seen with ACTH (5.8 f 0.2 litres/min). The combined steroid infusion also produced a small increase in cardiac rate (62 f 4 to 67 rf: 3 beats/min on day 5 of infusion).
Discussion
In the present study, ACTH-induced hypertension in the sheep was associated from onset with significant elevations of both cardiac output and cardiac rate. Calculated total peripheral resistance did not change over the 5 days of ACTH treatment.
The haemodynamic changes reported with steroid-induced hypertension are as conflicting as those in other models of hypertension. Studies in man after either administration of 9a-fluorocortisol to normal subjects (Distler & Philipp, 1976) or withdrawal of spironolactone in patients with primary aldosteronism (Distler, Just & Philipp, 1973) show an initial increase in cardiac output followed by a gradual rise in resistance and a return of cardiac output to control values. Studies of steroid-induced hypertension involving DOCA and salt administration in the pig (Terris, Berecek, Cohen, Stanley, Whitehouse & Bohr, 1976) or dog (Conway & Hatton, 1978) suggest that changes in cardiac output play a minor role.
The present studies provide comprehensive documentation of haemodynamic changes in a model of steroid-induced hypertension. Measurements were made daily in conscious animals and the haemodynamic profile was similar in all animals. This is in contrast to the studies by Bravo, Tarazi & Dustan (1978) in which only 5 of 1 1 dogs showed an increase in cardiac output when first measured after 14 days of metapyrone treatment. In the study by Conway & Hatton (1978) cardiac output was not measured until the third experimental day, when the dogs already had a significant rise in arterial pressure.
The mechanisms involved in the increase in cardiac output in ACTH-treated sheep are not clear. Although a redistribution of extracellular fluid from the interstitial space to the vascular compartment occurs within 24 h of ACTH treatment (Scoggins, Coghlan, Denton, Fan, McDougall, Oddie & Shulkes, 1975) this increase in plasma volume was not accompanied by an increase in stroke volume. Rather, a rise in heart rate was associated with the increase in cardiac output. The rapid return of cardiac output to pre-ACTH values on cessation of ACTH is associated with a marked diuresis and natriuresis and a fall in both plasma volume and extracellular fluid volume (Scoggins ef al., 1975) .
To determine whether the increase in cardiac output is essential for development of ACTH hypertension, ACTH was administered to animals during b-adrenoreceptor blockade. Blood pressure rose without any increase in cardiac output at 24 h similar to findings in the dog by Bravo et al. (1978) , and Conway & Hatton (1978) for 'mineralocorticoid' models of hypertension. Although cardiac output then rose progressively over the next 4 days in these &adrenoreceptor-blocked animals the hypertension was associated with increases in total peripheral resistance not seen without ACTH alone. These results in the sheep also confirm an earlier study in which bilateral surgical denervation of the adrenals failed to prevent either the tachycardia or the rise in blood pressure seen with ACTH treatment (Shulkes, Coghlan, Denton, Fan, Robinson & Scoggins, 1974) . Cardiac output measured after 5 days in the denervated animals was not significantly different from the pre-ACTH value.
The combined steroid-infusion experiments suggest that at least part of the change in cardiac output seen in ACTH hypertension may simply be associated with the effects of high circulating concentrations of steroids and not primarily related to development of the hypertension. After 5 days of combined steroid infusion changes in cardiac output were identical with those seen with ACTH although the effects on blood pressure were much less.
Hypokalaemia is a feature of ACTH administration in the sheep and 'mineralocorticoid' models of hypertension in other species. As potassium depletion alone will produce increases in cardiac output without changes in blood pressure (Knochel, Foley & Lipscomb, 1978; Galvez, Bay, Roberts & Ferris, 1977) hypokalaemia might play an important role in the ACTH hypertension model. Studies of this model of ACTH hypertension have led to the concept of 'hypertensinogenic' class of steroid hormone action rather than 'mineralocorticoid' or 'glucocorticoid' activities being solely responsible for the hypertension in steroid-induced models of hypertension (Coghlan, Denton, Fan, McDougall & Scoggins, 1976) . Further studies to elucidate the relationships between the various classes of steroid hormone activity and the observed haemodynamic changes they produce w i l l be required to fully understand the physiological mechanisms involved in ACTH hypertension.
